Getting Smarter in How We Score and Promote Value
May
Getting On Pathway?
Signaling the Future of Personalized Medicine
Money Well Spent?
SABCS Conference Coverage
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
Availability of Newer Agents May Lower Healthcare Costs
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology
UPMC Oncologists: Pioneers in the Clinical Pathways Movement
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Former USAID Health Chief Says Aid Cuts Are Costing Children's Lives
3
How ID, HIV Clinicians Can Influence Policy in an Election Year
4
It’s the Best of Times and Worst of Times for Cancer Care in Tampa
5